SHEILA MENDOZA: Open Payments
NPI 1396242665 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,372 in 161 payments from 24 companies in 2025. Trend: 2023 $4,090 · 2024 $4,121 · 2025 $4,372
Food & beverage: $3,596Travel & lodging: $690Education: $86
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 5 | $970 |
| UCB, Inc. | 18 | $457 |
| ABBVIE INC. | 27 | $433 |
| Amgen Inc. | 8 | $267 |
| Novartis Pharmaceuticals Corporation | 4 | $252 |
| Merz Pharmaceuticals, LLC | 8 | $246 |
| Eisai Inc. | 14 | $218 |
| Biogen, Inc. | 9 | $217 |
| Teva Pharmaceuticals USA, Inc. | 17 | $193 |
| GENZYME CORPORATION | 3 | $163 |
Products named: VNS Therapy, Leqembi, QULIPTA, KESIMPTA, Xeomin, UPLIZNA, Fintepla, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
